Correlation Between Starbucks and Pharmala Biotech
Can any of the company-specific risk be diversified away by investing in both Starbucks and Pharmala Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Starbucks and Pharmala Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Starbucks and Pharmala Biotech Holdings, you can compare the effects of market volatilities on Starbucks and Pharmala Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Starbucks with a short position of Pharmala Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Starbucks and Pharmala Biotech.
Diversification Opportunities for Starbucks and Pharmala Biotech
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Starbucks and Pharmala is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Starbucks and Pharmala Biotech Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmala Biotech Holdings and Starbucks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Starbucks are associated (or correlated) with Pharmala Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmala Biotech Holdings has no effect on the direction of Starbucks i.e., Starbucks and Pharmala Biotech go up and down completely randomly.
Pair Corralation between Starbucks and Pharmala Biotech
If you would invest 9,643 in Starbucks on September 5, 2024 and sell it today you would earn a total of 514.00 from holding Starbucks or generate 5.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 4.55% |
Values | Daily Returns |
Starbucks vs. Pharmala Biotech Holdings
Performance |
Timeline |
Starbucks |
Pharmala Biotech Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Starbucks and Pharmala Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Starbucks and Pharmala Biotech
The main advantage of trading using opposite Starbucks and Pharmala Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Starbucks position performs unexpectedly, Pharmala Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmala Biotech will offset losses from the drop in Pharmala Biotech's long position.Starbucks vs. Hyatt Hotels | Starbucks vs. Smart Share Global | Starbucks vs. Wyndham Hotels Resorts | Starbucks vs. WW International |
Pharmala Biotech vs. Rave Restaurant Group | Pharmala Biotech vs. The Wendys Co | Pharmala Biotech vs. Starbucks | Pharmala Biotech vs. Shake Shack |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Money Managers Screen money managers from public funds and ETFs managed around the world |